Il Dong Pharmaceutical Co Ltd (249420.KS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · South Korea · ISIN KR7249420001

Price
12,430.00 KRW
Market cap
391.65 bn KRW
P/E (2025)
14.16
P/S (2025)
0.69
Dividend yield
1.61 %
Net margin
4.88 %
Return on equity (ROE)
11.23 %
Return on assets (ROA)
4.83 %

Il Dong Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue614.94 bn KRW566.93 bn KRW
Gross profit233.46 bn KRW219.75 bn KRW
Operating income13.13 bn KRW19.50 bn KRW
EBIT5.25 bn KRW43.93 bn KRW
Net income-4.58 bn KRW27.66 bn KRW
Diluted EPS – continuing operations-163.83 KRW878.01 KRW

Full history since 2016, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Il Dong Pharmaceutical Co Ltd

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provides raw material drugs; health foods and foods; beverages; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. The company was founded in 1941 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.